Regulatory report: Czech Republic, May 2020

In the Czech Republic, pure CBD is not a scheduled substance under Czech law; the legality of the use of isolate and extracts – which have to always be THC-free – depends on additional regulations according to each product category. This regulatory report offers a thorough overview and analysis of the current regulatory regime in place in the Czech Republic, covering all laws and restrictions in relation to extracts and finished products, and medical and recreational cannabis.

Free Sample
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization